Vyndamax 61 MG capsule UD 30S
Ended Awarded
- Contract number
- SPE2DB25FB5TY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,694
Award facts
- Contract value 100% obligated
- $27,693.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). Valued at $27,693.94 with a firm fixed price structure, this non-set-aside delivery order is scheduled for completion by October 20, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's track record with DLA includes consistent delivery of diverse pharmaceutical products across multiple therapeutic domains through competitively awarded, firm fixed-price contracts. As a primary vendor within the Defense Health Agency's pharmaceutical supply chain, AmerisourceBergen continues to demonstrate capability in meeting federal medical procurement requirements for Vyndamax, an FDA-approved cardiovascular medication used in heart failure treatment.
Quick answers
Who was awarded contract SPE2DB25FB5TY?
SPE2DB25FB5TY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FB5TY worth?
The government has obligated $27,694 on SPE2DB25FB5TY.
Is contract SPE2DB25FB5TY an order under another contract?
Yes. SPE2DB25FB5TY is a delivery order under SPE2DB24D1007, an indefinite delivery contract.
Was contract SPE2DB25FB5TY competed?
The extent of competition for SPE2DB25FB5TY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award